Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia

Haematologica. 2018 Feb;103(2):e50-e54. doi: 10.3324/haematol.2017.177360. Epub 2017 Nov 16.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anemia, Sickle Cell / drug therapy*
  • Anti-Inflammatory Agents / therapeutic use
  • Child
  • Child, Preschool
  • Humans
  • Hydroxyurea / pharmacology
  • Hydroxyurea / therapeutic use*
  • Interferon alpha-2 / drug effects
  • Vascular Cell Adhesion Molecule-1 / drug effects

Substances

  • Anti-Inflammatory Agents
  • Interferon alpha-2
  • Vascular Cell Adhesion Molecule-1
  • Hydroxyurea